Hide

FocusBar

Subscribe to Premium Member
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 2356
RMTI's Cash to Debt is ranked higher than
55% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3750.67 vs. RMTI: 2356 )
RMTI' s 10-Year Cash to Debt Range
Min: 0.05   Max: No Debt
Current: 2356

Equity to Asset -0.678
RMTI's Equity to Asset is ranked lower than
90% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.53 vs. RMTI: -0.678 )
RMTI' s 10-Year Equity to Asset Range
Min: -0.68   Max: 0.81
Current: -0.68

-0.68
0.81
Interest Coverage No Debt
RMTI's Interest Coverage is ranked higher than
67% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 420.30 vs. RMTI: No Debt )
RMTI' s 10-Year Interest Coverage Range
Min: 1   Max: No Debt
Current: No Debt

F-Score: 3
Z-Score: -16.85
M-Score: -10.11
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -108.90
RMTI's Operating margin (%) is ranked lower than
82% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 5.80 vs. RMTI: -108.90 )
RMTI' s 10-Year Operating margin (%) Range
Min: -108.9   Max: 2.3
Current: -108.9

-108.9
2.3
Net-margin (%) -108.4
RMTI's Net-margin (%) is ranked lower than
82% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.25 vs. RMTI: -108.4 )
RMTI' s 10-Year Net-margin (%) Range
Min: -108.4   Max: 1.2
Current: -108.4

-108.4
1.2
ROA (%) -317.3
RMTI's ROA (%) is ranked lower than
87% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.40 vs. RMTI: -317.3 )
RMTI' s 10-Year ROA (%) Range
Min: -317.3   Max: 2.8
Current: -317.3

-317.3
2.8
Revenue Growth (%) -10
RMTI's Revenue Growth (%) is ranked higher than
56% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. RMTI: -10 )
RMTI' s 10-Year Revenue Growth (%) Range
Min: -10   Max: 26.5
Current: -10

-10
26.5
EBITDA Growth (%) 73.2
RMTI's EBITDA Growth (%) is ranked higher than
90% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: -1.10 vs. RMTI: 73.2 )
RMTI' s 10-Year EBITDA Growth (%) Range
Min: -20.9   Max: 73.2
Current: 73.2

-20.9
73.2
EPS Growth (%) 63.6
RMTI's EPS Growth (%) is ranked higher than
91% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. RMTI: 63.6 )
RMTI' s 10-Year EPS Growth (%) Range
Min: 0   Max: 63.6
Current: 63.6

0
63.6
ยป RMTI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2011

RMTI Guru Trades in Q2 2011

Steven Cohen 31,565 sh (New)
Jim Simons 89,200 sh (New)
» More
Q3 2011

RMTI Guru Trades in Q3 2011

Jim Simons Sold Out
Steven Cohen Sold Out
» More
Q4 2011

RMTI Guru Trades in Q4 2011

Jim Simons 21,500 sh (New)
» More
Q1 2012

RMTI Guru Trades in Q1 2012

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with RMTI



No Insider Trades Found!

Ratios

vs
industry
vs
history
P/S 1.50
RMTI's P/S is ranked lower than
59% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. RMTI: 1.50 )
RMTI' s 10-Year P/S Range
Min: 0.24   Max: 5.11
Current: 1.5

0.24
5.11
EV-to-EBIT 200
RMTI's EV-to-EBIT is ranked lower than
62% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 16.25 vs. RMTI: 200 )
RMTI' s 10-Year EV-to-EBIT Range
Min: 28.1   Max: 232.9
Current: 200

28.1
232.9

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 22
RMTI's Price/Net Current Asset Value is ranked higher than
92% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 8.90 vs. RMTI: 22 )
RMTI' s 10-Year Price/Net Current Asset Value Range
Min: 3   Max: 47.4
Current: 22

3
47.4
Price/Median PS Value 0.9
RMTI's Price/Median PS Value is ranked higher than
95% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.80 vs. RMTI: 0.9 )
RMTI' s 10-Year Price/Median PS Value Range
Min: 0.3   Max: 2
Current: 0.9

0.3
2
Earnings Yield (Greenblatt) 0.50
RMTI's Earnings Yield (Greenblatt) is ranked higher than
58% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 5.95 vs. RMTI: 0.50 )
RMTI' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.4   Max: 3.6
Current: 0.5

0.4
3.6
Forward Rate of Return (Yacktman) 48.07
RMTI's Forward Rate of Return (Yacktman) is ranked higher than
58% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.03 vs. RMTI: 48.07 )
RMTI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -7.4   Max: -1.9
Current: 48.07

-7.4
-1.9

Business Description

Rockwell Medical Inc formerly Rockwell Medical Technologies, Inc., incorporated in the state of Michigan in 1996, manufactures hemodialysis concentrate solutions and dialysis kits, and it sell, distribute and deliver these and other ancillary hemodialysis products primarily to hemodialysis providers in the United States as well as internationally primarily in Asia, Latin America and Europe. Hemodialysis duplicates kidney function in patients with failing kidneys also known as End Stage Renal Disease ('ESRD'). ESRD is an advanced stage of chronic kidney disease ('CKD') characterized by the irreversible loss of kidney function. Without properly functioning kidneys, a patient's body cannot get rid of excess water and toxic waste products. Without frequent and ongoing dialysis treatments, these patients would not survive. Its dialysis solutions (also known as dialysate) are used to maintain life, removing toxins and replacing nutrients in the dialysis patient's bloodstream. It manufacture, sell, distribute and deliver hemodialysis concentrates as well as a full line of ancillary hemodialysis products to hemodialysis providers and distributors located in 36 states and territories as well as a number of foreign countries, primarily in Asia. Latin America and Europe. Hemodialysis concentrates, which account for over 94% of its revenue, are comprised of two primary product types, which are generally described as acidified dialysate concentrate, also known as acid concentrate, and bicarbonate. Its competitor is a subsidiary of Fresenius Medical Care AG& Co. KGaA ('Fresenius'), which is primarily in the business of operating dialysis clinics but also manufactures and markets dialysis devices, drugs and supplies. It also competes against Cantel Medical Corp.'s subsidiary, Minntech Corporation ('Minntech').
Company Website
SEC Reports
Industry: Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ
Traded in other countries:RWM.Germany

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial